Aradigm Corporation  

(Public, NASDAQ:ARDM)   Watch this stock  
Find more results for OTC:ARDM
9.15
-0.10 (-1.08%)
Sep 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.90 - 9.47
52 week 6.60 - 15.96
Open 9.27
Vol / Avg. 13,914.00/22,789.00
Mkt cap 136.05M
P/E     -
Div/yield     -
EPS -1.20
Shares 14.71M
Beta 0.74
Inst. own 35%
Aug 11, 2014
Q2 2014 Aradigm Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -11.09% -221.92%
Operating margin -11.00% -204.92%
EBITD margin - -36.76%
Return on average assets -10.62% -72.62%
Return on average equity -13.27% -133.76%
Employees 12 -
CDP Score - -

Address

3929 Point Eden Way
HAYWARD, CA 94545
United States - Map
+1-510-2659000 (Phone)
+1-510-2658878 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aradigm Corporation is a specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company's lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100)), which is delivered by inhalation for the management of infections associated with the severe respiratory diseases cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis (BE).

Officers and directors

Virgil D. Thompson Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Igor Gonda Ph.D. President, Chief Executive Officer, Director
Age: 66
Bio & Compensation  - Reuters
Nancy E. Pecota Chief Financial Officer, Vice President - Finance
Age: 54
Bio & Compensation  - Reuters
Juergen Froehlich M.D. Chief Medical Officer
Age: 57
Bio & Compensation  - Reuters
David Bell Independent Director
Age: 59
Bio & Compensation  - Reuters
Lafmin Morgan Independent Director
Age: 49
Bio & Compensation  - Reuters
Helen E. Short Independent Director
Age: 64
Bio & Compensation  - Reuters
John M. Siebert Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters